July 07, 2026 01:07 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
China tests ballistic missile from nuclear submarine in Pacific: Australia, New Zealand respond | Baruipur horror: Main accused in alleged rape and murder of minor girl arrested; senior cops dissatisfied with handling of the case | Defence stocks jump after Rs 52,000 crore DAC approval sparks buying frenzy | 'Harry Kane is a great player': Donald Trump after England knocked Mexico out of the World Cup | 'Referee gave a lot against us': Harry Kane reacts after England's dramatic win over Mexico | England hold nerve with 10 men to knock out Mexico in five-goal World Cup classic | 'Why can't citizens protest against the government? They are being made slaves by slapping cases': Bombay HC slams Mumbai Police, quashes activist's externment | 'First he cheats on me...': Siya Goyal's old pub video goes viral amid probe into fiancé Ketan Agarwal's alleged murder | Ronaldo's goal, Ramos' last-gasp winner send Portugal past Croatia, set up Spain clash | India-US trade deal almost done! Piyush Goyal hints at breakthrough
Covidd-19 Vaccine

Vaccine by the end of 2020 possible, says Union health minister

| @indiablooms | Aug 31, 2020, at 10:47 pm

New Delhi/IBNS: Union health and family welfare minister Dr Harshvardhan said on Monday that a vaccine might be ready in the country by the end of this year, said media report.

The minister said India is not lagging behind anyone else in the world in efforts to contribute towards the development of a coronavirus vaccine.

There are 7-8 vaccine candidates, three of them in the clinical trial phase and the rest in the pre-clinical phase, he informed.

Currently, two vaccine candidates developed in India — Covaxin by Bharat Biotech and ZyCoV-D by Zydus Cadila are in the midst of phase II clinical trial, while Covishield by the University of Oxford has recently started the phase II clinical trial in India.

Vaccine manufacturer AstraZeneca has entered into an agreement with Serum Institute of India to manufacture Oxford's COVID-19 vaccine candidate for India and countries in the low-income group.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.